2009
DOI: 10.1080/00048670903107625
|View full text |Cite
|
Sign up to set email alerts
|

Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Study Design and Baseline Characteristics

Abstract: The present study improves on the previous studies because treatment was provided for 12 months and the independent contributions of psychological and pharmacological treatments in preventing transition to psychosis in the UHR cohort and on levels of psychopathology and functioning can be directly compared. Issues associated with recruitment and randomization are discussed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
62
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 75 publications
(64 citation statements)
references
References 49 publications
2
62
0
Order By: Relevance
“…Future work needs to provide further empirical validation of the phenomenological model of self-disturbance as a core vulnerability marker of schizophrenia spectrum disorders [see 18 ] and to further develop concepts for types of therapeutic intervention that specifically target psychotic vulnerability factors. The high prevalence of non-psychotic conditions in the UHR population [83,84] introduces the possibility of combining different psychotherapy strategies that target different types of disturbance. These efforts may lead to trialing psychotherapy interventions other than CBT in the UHR population.…”
Section: Discussionmentioning
confidence: 99%
“…Future work needs to provide further empirical validation of the phenomenological model of self-disturbance as a core vulnerability marker of schizophrenia spectrum disorders [see 18 ] and to further develop concepts for types of therapeutic intervention that specifically target psychotic vulnerability factors. The high prevalence of non-psychotic conditions in the UHR population [83,84] introduces the possibility of combining different psychotherapy strategies that target different types of disturbance. These efforts may lead to trialing psychotherapy interventions other than CBT in the UHR population.…”
Section: Discussionmentioning
confidence: 99%
“…These findings therefore may serve to raise awareness of the possible development of psychotic ideation in children with history of psychosocial adversity (Larkin & Read, 2008). Paying attention to (and treatment of) hallucinatory and delusional experiences in the earliest stages may be helpful in preventing possible transition to overt mental illness Phillips et al 2007Phillips et al , 2009). In addition, the effects of TE/SE on AVH persistence may be important, as previous work suggests that particularly persistence of psychotic experiences may result in need for care and formal diagnosis of psychotic disorder (Cougnard et al 2007 ;Dominguez et al 2009 ;Smeets et al 2010 ;Mackie et al 2011).…”
Section: Discussionmentioning
confidence: 99%
“…In a recent, more sophisticated double-blind placebocontrolled RCT, Phillips et al 57 compared the combinations of risperidone and CBT with placebo, and CBT or placebo and supportive therapy, in a group of UHR patients (n = 115). The 6-month transition rates were low in all 3 treatment groups, suggesting that antipsychotics may not be necessary in UHR patients who are detected early, or that recent UHR cohorts are derived from less so-called enriched samples for the true positive rate.…”
Section: Intervention Studies In Uhr Groupsmentioning
confidence: 99%
“…66,67 This generalized effect is appropriate for the UHR group, who have been found to have a wide variety of general psychiatric features, not only attenuated psychotic symptoms, and which are a target in their own right. 57 Applying the clinical staging model to treatment of the UHR population, the evidence reviewed above indicates that so-called gentler therapies such as EPA or psychosocial interventions, including CBT or supportive therapy, may be suitable as a first-line treatment in UHR patients. However, the clinical staging model does not necessarily mean eschewing study of the role of antipsychotic medication in this population.…”
Section: Intervention Studies In Uhr Groupsmentioning
confidence: 99%